Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

FDA Approves Multiple Sclerosis Therapy

The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease. . . . → Read More: FDA Approves Multiple Sclerosis Therapy

Trials, Registry Planned for Wound Care Device

A company making products for healing wounds is studying the ways one of its dressings is used in the field, to better understand the product’s role in wound care. . . . → Read More: Trials, Registry Planned for Wound Care Device

Report: More Biotech Regulations Needed, and Soon

A new report from the National Academies calls for a more robust and responsive regulatory system to handle an anticipated flood of biotechnology products. . . . → Read More: Report: More Biotech Regulations Needed, and Soon

Trial Shows Bioactive Glass Stops Bone Infections

Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics. . . . → Read More: Trial Shows Bioactive Glass Stops Bone Infections

Trial Underway to Test Cancer Immunotherapy Aid

A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system. . . . → Read More: Trial Underway to Test Cancer Immunotherapy Aid

Mobile App-Controlled Patch Reduces Migraine Pain

A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines. . . . → Read More: Mobile App-Controlled Patch Reduces Migraine Pain

Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma

A clinical trial testing synthetic immune system cells shows after 6 months the cells can generate a full or partial response in many patients with non-Hodgkin lymphoma. . . . → Read More: Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma

Trial Begins Testing Enhanced Cord Blood Stem Cells

A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient. . . . → Read More: Trial Begins Testing Enhanced Cord Blood Stem Cells

Public Access to Drugs Meets Health Needs, Cuts Costs

A study shows adding universal access to essential drugs as part of Canada’s health care system would meet much of that country’s pharmaceutical needs and save billions of dollars. . . . → Read More: Public Access to Drugs Meets Health Needs, Cuts Costs

Biofeedback Device Reduces Panic Attacks in Trial

A medical device that provides people with panic disorder feedback on their abnormal breathing is shown in a clinical trial to reduce panic severity 12 months after treatment. . . . → Read More: Biofeedback Device Reduces Panic Attacks in Trial